Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2025 May 28;40(8):1692–1703. doi: 10.1002/mds.30232

Neural Mechanisms of Object Location Memory in Huntington's Disease

Yifat Glikmann‐Johnston 1,, Garance Delagneau 1, Tamrin Barta 1, Julie C Stout 1, Adeel Razi 1,2,3
PMCID: PMC12371679  PMID: 40432572

ABSTRACT

Background

Object‐location memory impairment in Huntington's disease (HD) occurs from premanifest period and declines as HD progresses, however, pathogenesis of object‐location memory is unknown. The striatum and hippocampus are affected in HD, functionally interacting allowing intact object‐location memory.

Objectives

The present study investigated if object location memory impairment in premanifest and manifest HD was associated with aberrations in effective connectivity between striatum and hippocampal formation.

Methods

Using dynamic causal modelling, we examined effective connectivity between the striatum and hippocampus and association with object‐location memory in 35 HD participants (23 premanifest, 12 early manifest) and 32 controls.

Results

HD participants' object‐location memory was worse than controls, with performance associated with aberrant effective connectivity from the striatum to hippocampal formation, lower connectivity was associated with poorer object‐location memory. Connectivity from hippocampal formation to the striatum was lower in manifest HD. In premanifest HD, connectivity from parahippocampal gyrus to the striatum was stronger and associated with better object‐location memory.

Conclusions

Findings raise questions regarding compensatory neural processes in HD and other neurodegenerative diseases, providing pathophysiological evidence that cognitive impairment may be related to connectopathy. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: caudate nucleusfunctional MRIputamenspatial memorytemporal lobe|


Spatial memory impairment occurs in Huntington's disease (HD) before the emergence of motor signs in premanifest HD and becomes more pronounced as HD progresses into manifest stages where motor signs are apparent. 1 The impact of spatial memory impairment on daily life is significant. “For me, it started with small, unexplained absences: car keys, glasses, a million lighters, shoes, clothes. Then I lost the world, city by city. Familiar places became a scary tangle of streets, so I stayed in the house.” (Extracted from The Guardian by Charlotte Raven, Living with Huntington's disease: “For our family, the end of days is always close at hand”, October 16, 2021). Remembering where things are in the environment is called object location memory, which is a component of spatial memory essential for many life activities. We have recently shown that object location memory impairment in manifest HD and in premanifest HD many years from estimated motor onset (>10 years). 1 This finding is important because 10 to 20 years before motor onset, people are thought to be asymptomatic with intact cognition. 2 Having detected changes in object location memory in presymptomatic HD may suggest this cognitive domain is highly sensitive to HD, however, the pathogenesis of object location memory in HD is unknown.

Neurocognitively, the striatum (caudate nucleus, putamen, and ventral striatum) and hippocampal formation (hippocampus proper and adjacent parahippocampal cortices) are key brain structures for both object location memory and HD. Atrophy in the striatum is the hallmark radiological finding in HD. 3 The hippocampus also undergoes early atrophy at a smaller magnitude compared to the striatum, and mostly after motor onset. 4 , 5 Whole brain diffusion magnetic resonance imaging (MRI) did not show connectivity loss between the hippocampus and striatum in either premanifest or manifest HD 6 suggesting that the functional disconnection between the striatum and hippocampus may occur before hippocampal structural loss. Both hippocampus and striatum mediate spatial memory, including object location memory. 7 The striatum implements object location memory in relation to one's body location and objects in the environment, termed egocentric spatial mapping. 7 The hippocampal formation implements spatial mapping through a cognitive map of objects within the environment, independent of one's body orientation, termed allocentric. 8 The striatum and hippocampus are connected anatomically and interact functionally to enable intact spatial memory, including object location. 9

In HD, the interaction between the striatum and hippocampus during spatial memory has been shown in one publication, which demonstrated altered connectivity during route recognition, a component of spatial memory. 10 Voermans et al 10 showed premanifest and manifest HD participants video sequences of first‐person fixed virtual home routes followed by route recall. HD participants maintained close to normal performance, however, underlying brain activity varied between groups. Compared to controls, task‐based functional MRI (fMRI) showed that HD participants had higher hippocampal activity, alongside reduced functional connectivity between the caudate nucleus and hippocampus. The authors suggested a compensatory process helps to overcome the declining function of the caudate nucleus to maintain normal route recall. Although these results highlight the cooperation between the striatum and hippocampus in spatial memory, they do not establish the direction or valence (eg, inhibition or excitation) of the interaction. Further, given that spatial memory is not a unitary or internally homogenous and includes many different components such as navigation, object location, and route recognition, we cannot assume the observed striatum‐hippocampus cooperation in route recognition will be seen in other spatial memory components or in the domain as a whole. 11

Directional and functional interactions between the striatum and hippocampus, and their association with object location memory, can be studied using effective connectivity. Effective connectivity refers to the causal influences one neural system applies over another, 12 , 13 and can be estimated using dynamic causal modelling (DCM). DCM uses a Bayesian framework for developing a generative model of directed or causal influences between brain regions comprising spatially distributed neural systems. 12 Here, we used spectral DCM 13 , 14 , 15 to characterize striatum‐hippocampal formation effective connectivity in premanifest HD, early manifest HD, and matched controls using resting‐state fMRI data. DCM has been successfully used to demonstrate effective connectivity alterations in HD, including fMRI motor task‐induced connectivity changes predictive of disease progression. 16 Based on previous HD DCM study with a cognitive task showing decreased connectivity in a network underlying verbal working memory, 17 we tested two hypotheses: (1) there would be reductions in connectivity between the striatum and hippocampal formation in premanifest and manifest HD; and (2) reduced striatum‐hippocampal formation effective connectivity would be associated with worse object location memory in HD.

Subjects and Methods

Participants

This study included 35 HD gene expansion carriers, including 23 premanifest HD and 12 early manifest HD, and a comparison group of 32 healthy controls, using the sample from Glikmann‐Johnston et al,11 with available fMRI and object location memory data. There were more premanifest HD participants who could fulfil and study inclusions and perform fMRI and cognitive testing than manifest HD participants, hence the unequal sample size of the HD groups. HD participants, age 30 to 66 years with genetically confirmed CAG expansions (≥36 repeats), were recruited through Calvary Health Care Bethlehem Hospital and ENRU‐Stout HD data base at Monash University (Melbourne, Australia). Exclusion criteria included major neurological illness (except HD), significant head injury, or non‐HD‐related psychiatric disturbances. Premanifest HD participants had never received clinical diagnosis of HD, as indicated by the Unified Huntington's Disease Rating Scale (UHDRS) diagnostic confidence levels <4. 18 Early stage HD participants showed minimal to moderate clinical impairments as indicated by the UHDRS total functional capacity (TFC) scores of >7. 18

None of the premanifest HD and 21.4% of our early stage HD participants were taking dopamine antagonists, and 12.5% of premanifest HD and 42.8% of early stage HD participants were taking antidepressant medication at the time of study participation. Because of the different types and varying doses of medication in these groups, it was not possible to add these as covariates in the analysis. Nevertheless, we examined the association between medication and object location memory, our main focus here, and directly compared those taking to those not taking either antidepressants or dopamine antagonists. This analysis produced non‐significant result (P > 0.1), therefore, we concluded that medication did not significantly influence performance in this study.

Given the progressive nature of HD, the manifest HD group was older than the premanifest HD group (t(33) = −3.28, P = 0.002), had higher UHDRS total motor scores (TMS) (t(10.69) = −6.1, P < 0.001), lower UHDRS TFC scores (t(11.66) = 2.51, P = 0.028), and higher disease burden scores (DBS) (given by: age × CAG‐35.5; 19 t(33) = − 2.39, P = 0.022) than the premanifest HD group. Gender distribution between premanifest and manifest HD groups did not differ significantly (χ2(1, n = 35) = 2.394, P = 0.122). Control participants were matched to individual HD participants based on age (within 5 years), handedness, gender, and estimated intelligence quotient (IQ) (within the same range). At group level analyses (controls vs. HD group combined of premanifest and manifest) there were no differences in age (t(65) = −0.20, P = 0.846), gender (χ2(1, n = 67) = 0.014, P = 0.907), handedness (χ2(1, n = 67) = 0.130, P = 0.718), or estimated IQ (t(65) = 1.38, P = 0.171). The groups did not differ in depressive symptomology (t(65) = −1.52, P = 0.879) (Table 1). All participants gave written informed consent in accordance with the Declaration of Helsinki. Procedures were approved by the Human Research Ethics Committees of Monash University and Calvary Health Care Bethlehem Hospital, Melbourne Australia.

TABLE 1.

Participant characteristics and clinical data

Premanifest HD (n = 23) Manifest HD (n = 12) Controls (n = 32)
Age Mean (SD) 45.61 (8.25) 55.17 (7.99) 48.47 (8.06)
Median 46 55 49.50
Range 30–59 43–66 35–65
Female % 60.9 33.3 50
Right‐handed % 87.5 100 93.80
Estimated FSIQ a Mean (SD) 106.65 (9.39) 109.08 (9.15) 110.50 (8.52)
Median 107 108.5 111.50
Range 87–126 95–123 91–127
CESD‐R scale Mean (SD) 8.96 (11.92) 9 (9.70) 8.59 (8.98)
Median 4 6 5.50
Range 0–42 0–29 0–37
CAG repeats Mean (SD) 41.78 (1.81) 41.92 (1.44) N/A
Median 42 42 N/A
Range 38–45 39–44 N/A
DBS Mean (SD) 280.76 (83.27) 346.67 (63.70) N/A
Median 260 337.75 N/A
Range 140–420 227.5–484.5 N/A
UHDRS TMS confidence Mean (SD) 0.14 (0.36) 3.91 (0.30) N/A
Median 0 4 N/A
Range 0–1 3–4 b N/A
UHDRS TMS frequency Mean (SD) 1.33 (2.43) 19.18 (9.54) N/A
Median 0 19 N/A
Range 0–8 9–40 N/A
UHDRS TFC Mean (SD) 12.74 (0.62) 10.83 (2.59) N/A
Median 13 12.50 N/A
Range 11–13 7–13 N/A

Abbreviations: HD, Huntington's disease; FSIQ, Full Scale Intelligence Quotient; CESD‐R, Center for Epidemiologic Studies Depression Scale‐Revised; 19 CAG, cytosine adenine guanine; DBS, disease burden score; 17 UHDRS, Unified Huntington's Disease Rating Scale; TMS, total motor score;16 TFC, total functional capacity.

a

FSIQ was estimated using the National Adult Reading Test second edition. 18

b

One participant obtained a score of 3 (= motor abnormalities that are likely signs of HD with 90%–98% confidence) because of a leg injury that happened close to the motor assessment, which made it difficult to establish 99% confidence (score of 4).

Procedure

Testing took 2 hours and was consistent for all participants. The first hour included testing of object location memory via a virtual house. 1 Then, participants underwent a 30‐minute MRI protocol. During scanning, participants lay still and could close their eyes for the structural scans. Next, participants completed clinical examination, including an assessment of premorbid IQ using the National Adult Reading Test second edition, 20 screening for depression with the Center for Epidemiologic Studies Depression Scale‐Revised, 21 and other cognitive testing (including Rey Complex Figure Test, Paired Associates Learning, Symbol Digits Modalities Test, see Glikmann‐Johnstons et al11). A trained cognitive examiner administered clinical assessments. To minimize bias, participants were assigned a number, and analyses were conducted using unique participant identifications (IDs).

Resting‐State fMRI

Brain MRI Acquisition and Pre‐Processing

MRI scanning was conducted using a 3‐Tesla Siemens Skyra MRI scanner (Siemens Magnetom, Malvern, PA, USA) at Monash Biomedical Imaging Research Centre (Melbourne Australia). Images acquired included T1‐weighted images (echo spacing = 6.3 ms, repetition time [TR] = 2300 ms, echo time [TE] = 2.07 ms, flip angle = 9°, slice thickness = 1.0 mm, interpolated voxel size = 1.0 × 1.0 × 1.0 mm3, field of view [FOV] = 256 mm, acquisition time = 7 minutes, 50 seconds) and resting‐state functional data (BOLD echoplanar imaging, 42 slices, TR = 2350 ms, echo spacing = 0.65 ms, TE = 30.0 ms, flip angle = 90°, slice thickness = 3.0 mm, interpolated voxel size = 3.0 × 3.0 × 3.0 mm3, FOV = 192 mm, acquisition time = 8 minutes, 1 second). During resting‐state fMRI, examiners instructed participants to follow an eyes‐open resting‐state protocol while fixating a black cross.

A total of 201 functional images were collected. The first five echo planar imaging sequences were discarded to allow for steady‐state equilibrium, leaving 196 volumes. Resting‐state fMRI were analyzed using statistical parametric mapping (SPM12) (https://www.fil.ion.ucl.ac.uk/spm/) in MATLAB 2018b (The MathWorks, Natick, MA, USA). The preprocessing pipeline included slice‐time correction (using the central slice of each volume as a reference), realignment to the first functional volume of each session, spatial normalization to Montreal Neurological Institute (MNI) space, and spatial smoothing by a 6 mm full‐width half‐maximum Gaussian kernel. Head motion was considered acceptable for all participants (<3 mm).

Selection and Extraction of Volumes of Interest

Eight brain regions were identified as implicated in spatial memory and HD: bilateral hippocampi, parahippocampi, caudate nuclei and putamen. 7 , 22 , 23 , 24 , 25 Masks were created for each region of interest (ROI; left/right separately). Parahippocampus masks were created using WFU PickAtlas. 26 Caudate nuclei, putamen, and hippocampi were manually segmented using ITK‐SNAP. 27 This procedure has been described in detail elsewhere. 11 In brief, segmentation was based on a standard atlas 28 and followed validated protocols previously described (caudate nucleus, 29 putamen, 30 and hippocampus 31 ). Using ITK‐SNAP, a total volume (mm3) was obtained for each brain structure. Volumes were normalized per Free et al 32 to account for individual differences in head size (for each hemisphere separately). Analyses were performed using the normalized volumes. Researchers performing manual segmentation were blinded to group allocation. Intra‐class correlation coefficient values, used to measure inter‐rater reliability, ranged between 0.97 (left caudate nucleus) and 0.99 (left putamen).

Spectral DCM

First Level Spectral DCM Analyses

Effective connectivity was estimated using spectral dynamic causal modelling (spDCM) for resting‐state fMRI, which was specified and inverted using DCM12 (Supplementary Data S1). We modelled data using a Bayesian hierarchical random‐effects model. At the first level, a fully connected model (64 connections) was created for each participant. We estimated the DCMs using spDCM, fitting the cross‐spectral density using a parameterized power‐law model of endogenous neural fluctuations. This analysis provided measures of directed (causal) interactions between regions. 14

Second Level spDCM Analyses

Once the individual level spDCM were computed, group‐level analysis was performed using a parametric empirical Bayes (PEB) framework to characterize how group differences in neural circuitry were modulated by HD classification. 33 Three groups were compared: controls, pre‐manifest HD, and manifest HD. Bayesian model reduction was used to test all combinations of parameters within each parent PEB model and “pruned” redundant model parameters. 33 A Bayesian model averaging (BMA) approach quantified the strength of model connectivity parameters among regions. 33 Only parameters exceeding the threshold of posterior probability >0.95, corresponding to strong evidence, were interpreted. Gender was used as a covariate in all group‐level analyses.

Leave‐one‐out cross validation was performed for each connection that reached the significance criterion—posterior probability >95—from the group level analyses. 34 Analyses were performed separately for each group, and fitted the PEB model in all but one participant to predict variables of interest for the left‐out participant. This is repeated with each participant to assess averaged prediction accuracy.

Object Location Memory

Object location memory was tested using the virtual house, which mimics spatial demands of everyday life. 1 , 11 The house was a square structure comprising eight spaces (Fig. 1). Each space contained objects in conventional positions (eg, a picture on the wall, a chair at a table) and additional objects in arbitrary locations (eg, a big tap hanging off the wall, a model ship on a table). These objects formed test objects within the task. Of 11 test objects, three were geometric shapes (yellow sphere, pink cylinder, and blue rectangle), and eight were common objects (ship, tap, model car, shark, flower vase, balloon, piano, and fire extinguisher). The three shapes appeared 15 times in various locations, and each common object appeared once and in one room. Views to the environment exterior of the house varied according to the cardinal compass points toward which they were oriented.

FIG. 1.

FIG. 1

The virtual house. (A) Floor plan; (B) a view of conventional items located within the house (eg, chairs, table, and painting); (C) a room where test objects are present (tap, pink cylinder); and (D) where test objects are absent in the object location memory task. [Color figure can be viewed at wileyonlinelibrary.com]

The virtual house task began with a participant‐directed exploration phase, lasting 30 minutes minimum and 45 minutes maximum. An examiner was present while participants explored the virtual house. We did not observe effects of motor deficits in our HD cohort on operating the joystick, although latency effects were not measured. Testing object location memory immediately followed as well as other spatial components. 1 Participants viewed a screen displaying the test objects, which the examiner named aloud. Participants then re‐entered the house and were taken on a prescribed route by the examiner (who controlled the joystick), where test objects had been removed and replaced by a pale blue three‐dimensional transparent box (Fig. 1D). All conventionally placed objects (tables, chairs, and pictures) remained in the virtual house. Participants were instructed to recall missing test objects that had occupied the position marked by a pale blue transparent box. The outcome measure was recall of each object in its correct location, which had a maximum score of 23 points.

To compare object location memory performance between groups on the virtual house we used one‐way analysis of covariance (ANCOVA) with post hoc pairwise comparisons for main effect and Bonferroni adjustment for multiple comparisons.

Results

Group Differences in Striatal‐Hippocampal Formation Effective Connectivity

Compared to healthy controls, manifest HD participants showed lower connectivity from the right hippocampus to left caudate nucleus and from the right putamen to left parahippocampal gyrus. We found a similar connectivity pattern from the striatum to the hippocampal formation in the premanifest HD group when compared to healthy controls, with lower connectivity from the right caudate nucleus to left hippocampus and lower connectivity from the left caudate nucleus to right hippocampus. In contrast, there was stronger connectivity from the right parahippocampal gyrus to right caudate nucleus in premanifest HD compared to healthy controls. All connections were inhibitory, except the excitatory connection from left caudate nucleus to right hippocampus in the premanifest HD group (Table 2, Figs. 2 and 3).

TABLE 2.

Group differences in striatal‐temporal lobe connectivity and associations with object location memory performance

Valence Connection pHD vs. controls (↑/↓) mHD vs. controls (↑/↓) Connectivity effect size in Hz [95% CI] Association with object location in pHD a Association with object location in mHD a
Inhibitory PHGright → CNright 0.15 [0.08–0.22] 0.11 [0.07–0.14]
Inhibitory CNright → HPCleft 0.10 [−0.16 to −0.04] −0.08 [−0.12 to −0.03]
Excitatory CNleft → HPCright 0.11 [−0.16 to −0.06] −0.04 [−0.06 to −0.02]
Inhibitory CNleft → CNleft 0.10 [0.02–0.19] −0.10 [−0.15, −0.05]
Inhibitory HPCright → CNleft 0.17 [−0.25 to −0.09] −0.07 [−0.11 to −0.04]
Inhibitory PUright → PHGright 0.12 [−0.20 to −0.04] −0.14 [−0.17 to −0.12]
Excitatory HPCright → HPCleft 0.17 [0.10–0.24] −0.04 [−0.06 to −0.01]
Inhibitory PHGleft → PHGright 0.19 [−0.28 to −0.10] 0.04 [0.02–0.07]
Inhibitory CNright → CNright 0.19 [0.08–0.31] 0.11 [0.09–0.14]
Excitatory PUright → PUleft 0.09 [−0.17 to −0.02] −0.07 [−0.10 to −0.05]

Abbreviations: pHD, premanifest Huntington's disease; mHD, manifest Huntington's disease; ↑, increase in connectivity; ↓, decrease in connectivity; PHG, parahippocampal gyrus; HPC, hippocampus; CN, caudate nucleus; PU, putamen.

a

These numbers represent normalized β coefficients. Negative association suggests worse object location memory and positive association suggests better performance.

FIG. 2.

FIG. 2

Effective connectivity in premanifest Huntington's disease participants compared to controls. [Color figure can be viewed at wileyonlinelibrary.com]

FIG. 3.

FIG. 3

Effective connectivity between manifest Huntington's disease participants compared to controls. [Color figure can be viewed at wileyonlinelibrary.com]

We also found significant intra‐striatal and intra‐hippocampal formation connections in both HD groups when compared to controls. In the manifest HD group, there was stronger inhibition in the right caudate nucleus and excitatory decrease in connectivity from the right to left putamen. In the hippocampal formation of the manifest HD group, there was greater excitatory connectivity from right to left hippocampus and weaker inhibitory connectivity from left to right parahippocampal gyrus. In the premanifest HD group, there was stronger inhibition in the left caudate nucleus, but no significant intra‐hippocampal formation connections when compared to healthy controls.

Object Location Memory Performance and Associations to Striatal‐Hippocampal Formation Effective Connectivity

Consistent with previous findings, 1 , 11 object location memory performance significantly differed between groups (F (2,63) = 7.67, P = 0.001; controlling for gender), with both premanifest and manifest HD participants recalling significantly fewer test objects than healthy controls (premanifest HD: 8.72 ± 4.16 vs. controls: 12.41 ± 4.30, P = 0.008; manifest HD: 7.69 ± 4.25 vs. controls: 12.41 ± 4.30, P = 0.006). Performance did not differ significantly between premanifest and manifest HD groups (P = 1.0).

Object location memory in manifest HD was associated with lower connectivity from the right hippocampus to left caudate nucleus and from the right putamen to left parahippocampal gyrus. In those associations, worse memory performance was related to weaker striatal‐hippocampal formation connections. In premanifest HD, we found a similar pattern where worse memory was associated with weaker connectivity (ie, right caudate nucleus to left hippocampus; left caudate nucleus to right hippocampus). In contrast, hippocampal formation to striatum associations with object location memory showed that stronger connectivity from the right parahippocampal gyrus to right caudate nucleus was associated with better object location memory (Table 2, Figs. 4 and 5).

FIG. 4.

FIG. 4

Effective connectivity associated with the object location memory task in premanifest Huntington's disease participants compared to controls. [Color figure can be viewed at wileyonlinelibrary.com]

FIG. 5.

FIG. 5

Effective connectivity associated with the object location memory task in manifest Huntington's disease participants compared to controls. [Color figure can be viewed at wileyonlinelibrary.com]

For intra‐striatal and intra‐hippocampal formation connectivity associations with object location memory, in manifest HD stronger connectivity within the right caudate nucleus was associated with better object location memory, and weaker right to left putamen connectivity was associated with worse performance. In the hippocampal formation of manifest HD, stronger connectivity from right to left hippocampus was associated with worse object location memory, and weaker connectivity from left to right parahippocampal gyrus was associated with better performance. In premanifest HD, increased connectivity within the left caudate nucleus was associated with worse object location memory performance.

Discussion

Using spDCM, object location memory impairment in HD was associated with disruptions in effective connectivity between the striatum and hippocampal formation. Our findings do show that both premanifest and manifest HD participants exhibit reduced connectivity from the striatum to the hippocampal formation. However, there are key differences in directionality and lateralization. In premanifest HD, there is stronger connectivity from the parahippocampal gyrus to the striatum, which is associated with better object location memory, suggesting potential compensatory processes. Conversely, in manifest HD, the connectivity from the hippocampal formation to the striatum is reduced, and intra‐striatal and intra‐hippocampal connectivity patterns also show distinct alterations. These results suggest that although a general pattern of disrupted connectivity is present across HD stages, the specific direction and lateralization of these disruptions evolve as the disease progresses.

We found lower connectivity from the striatum to hippocampal formation in premanifest and manifest HD, which was associated with worse object location memory. This finding is not surprising given severe and early degeneration of the striatum in HD, 3 however, we know of no previous HD research empirically demonstrating a link between the striatum and hippocampal formation and object location memory. Vice versa, connectivity from the hippocampal formation to striatum was lower in manifest HD, but in premanifest HD, connectivity from the parahippocampal gyrus to striatum was stronger and associated with increasing object location memory. The connectivity profile of the premanifest HD sample is commensurate with other task fMRI studies, which together with normal cognitive performance hypothesized neural compensation. 10 , 35 , 36 The critical difference between our findings and previous studies is that premanifest HD participants performed significantly worse than healthy controls on the object location memory task while their effective connectivity was stronger, raising questions regarding the sensitivity of cognitive tasks for HD in the neural compensation hypothesis.

In HD, striatal volume loss is detectable up to 20 years before clinical diagnosis, 37 , 38 , 39 , 40 , 41 yet cognitive decline becomes apparent approximately 10 years before diagnosis. Compensatory neural processes are thought to account for the preservation of cognitive function in the presence of brain pathology or differences in fMRI metabolic activity in task‐dependent regions when compared to controls. 16 , 35 , 42 , 43 , 44 , 45 , 46 According to the neural compensation hypothesis, neurodegeneration and cognitive dysfunction are partially overcome by either reorganization of existing brain networks' connectivity (eg, increasing efficiency of information processing) and/or recruiting new regions to the network. 35 The DCM literature is mixed with regard to compensation mechanism in premanifest HD. In the large multicenter TrackOn‐HD study, 47 results were consistent with compensation and characterized by strengthened functional coupling between right dorsolateral prefrontal cortex and a left hemisphere network, which predicted better performance on the verbal n‐back task despite brain atrophy. In contrast, no indication of compensation was found for the motor network in a different premanifest HD cohort. 16 Mixed compensation results are seen in a visuospatial working memory task with varying difficulty levels 48 where premanifest HD made more errors at high difficulty level, but performed normally at low‐intermediate difficulty levels. In contrast to compensation, left intraparietal sulcus was reduced at high difficulty, with no fMRI over‐activation at lower task difficulty when compared to healthy controls. The changes we found in effective connectivity fits with neural atrophy in premanifest HD, suggesting the brain responds to pathology by altering how and where processing takes place. 35 In contrast, our findings of object location memory impairment of premanifest HD does not fit the neural compensation pattern, suggesting the cognitive aspect of the neural compensation hypothesis should be revisited.

An alternative explanation to the increased effective connectivity in premanifest HD could be related to increased pathological connectivity such as glutamate excitotoxicity seen in premanifest HD. In the HD‐YAS (Huntington Disease — Young Adult Study) cohort, 49 there was an increase in functional connectivity in the context of increasing cerebrospinal fluid neurofilament light (NfL), which is a marker of axonal degeneration that correlates with HD progression. 50 McColgan et al 49  also showed that regions with increased functional connectivity were also those with regional expression of genes specific to neuronal GABAergic and glutamatergic cells. This finding is consistent with evidence of neuronal network hyperexcitability driven by glutamatergic excitotoxicity and/or reduced inhibitory GABAergic activity in the earliest stages of neurodegeneration, 51 , 52 and suggesting that the increased effective connectivity that we have seen in our cohort may be pathological.

Cognitive changes in premanifest and early HD are subtle and selective for particular cognitive functions, and in later stages when neurodegeneration is extensive, a wide range of functions are affected. Early cognitive changes include psychomotor slowing, executive dysfunction, and inefficiencies in attention, working memory, and emotion recognition. 53 , 54 , 55 Spatial memory impairment, and specifically, object location memory impairment, have only recently shown to be an early cognitive change 56 , 57 even in those who are far from disease onset and considered presymptomatic. 2 Object location memory is the building block of environmental representation. 58 , 59 Successful recollection of object location requires several functional steps, including object processing, spatial location processing, and binding objects to locations. 60 As such, object location memory is considered a special class of episodic memory, reflecting a form of contextual memory where object (identity) information is bound to location information. 60 Deterioration of anterograde episodic memory is a well‐known early cognitive change in HD, which has been predominantly shown in the verbal domain. 55 Given both the cognitive and connectivity findings, it may be that object location memory is more sensitive to detect cognitive changes in premanifest HD than previous tasks used in fMRI studies to demonstrate neural compensation.

Although DCM has not been used widely in HD neuroimaging studies, our results complement one previous cognitive DCM study showing altered effective connectivity in a large HD sample. 17 Lahr et al 17 showed decreased DCM connectivity in a network underlying working memory during a verbal n‐back fMRI with low‐high levels of working memory. The lowest levels of connectivity were at right dorsolateral prefrontal cortex in premanifest HD, and more so in early manifest HD. HD participants performed less accurately and more slowly at high working memory load compared with controls. Together, we suggest that cognitive impairment in HD may be related to connectopathy, abnormal interactions between brain regions mediating cognitive function and the pathophysiology of HD, in contrast to localized dysfunction within specific brain regions. 61 , 62 The ventral striatum receives direct projections from the hippocampus, and these striatum‐hippocampus interactions enable a flexible spatial response that combines egocentric and allocentric spatial processing during context‐dependent spatial decision making. 9 HD neurodegeneration disrupts these striatal‐hippocampal connections, in turn impairing processing of spatial elements.

Neurocognitively, a limitation of our study is the focus on the striatum and hippocampal formation despite object location memory being mediated by a larger brain network. Our rationale for this focus was twofold 1 : there is an overlap in the involvement of these brain structures in object location memory and in HD, especially the striatum that is a central component in the spatial memory network 7 and striatal degeneration is a hallmark HD neuropathology. 2 , 63 DCM is ROI‐based, hypothesis‐driven, inference technique where a few regions are chosen to limit the computational complexity of the model fitting and ensuring robust statistical inference especially for small sample sizes. Although our DCM and behavioral results were significant and consistent with the cognitive DCM study by Lahr et al, 17 results are based on a smaller sample and should be interpreted with caution. Particular caution should be taken when interpreting results of the manifest HD group given the sample size of 12 participants.

We illuminate the neural correlates of a poorly characterized cognitive phenotype of HD, object location memory. The profile of effective connectivity linked to object location memory impairment in premanifest and manifest HD provides support to include object location memory in neuropsychological examination or clinical trials with cognitive endpoints, although more work is needed to show longitudinal change over the time period of a typical clinical trial. Object location memory is used in preclinical cognitive assessments in rodents, which precede clinical trials in humans, to assess the effects of potential treatments. 64 , 65 , 66 The availability of a cognitive construct sensitive in both HD animal models and humans can align better cognitive testing across species in HD clinical trials and increase the likelihood that what is observed in the mouse will be seen in people.

Author Roles

(1) Research project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript Preparation: A. Writing of the First Draft, B. Review and Critique.

Y.G.J: 1A, 1B, 1C, 2A, 2B, 2C, 3A

G.D: 1C, 2B, 2C, 3A

T.B: 2B, 2C, 3B

J.C.S: 3B

A.R: 1A, 1B, 1C, 2A, 2B, 2C, 3B

Financial Disclosures

Y.G.J. has no financial disclosures. G.D. has no financial disclosures. T.B. was funded by The Australian Government Research Training Program scholarship. J.C.S. has provided paid consulting services through Stout Neuropsych Pty Ltd to the following pharmaceutical sponsors in the past 12 months, including Skyhawk, Therapeutics, uniQure NV, LifeEdit Therapeutics, and Sage Therapeutics. J.C.S. is also a Director of Zindametrix Pty Ltd, a contract research organisation that provides services for implementation of cognitive assessments in HD clinical trials and has received compensation for Zindametrix activities in the past 12 months. A.R. is funded by the Australian Research Council (DE170100128 and DP200100757) and National Health and Medical Research Council (1194910) and CIFAR, Brain, Mind, and Consciousness Program.

Supporting information

Data S1. Supporting Information.

MDS-40-1692-s001.docx (15.2KB, docx)

Acknowledgment

Open access publishing facilitated by Monash University, as part of the Wiley ‐ Monash University agreement via the Council of Australian University Librarians.

Relevant conflicts of interest/financial disclosures: The authors declare that there are no conflicts of interest relevant to this work.

Funding agencies: A.R. was funded by the Australian National Health and Medical Research Council (Investigator Grant 1194910) for this work. Y.G.J. was funded by the National Health and Medical Research Council and Australian Research Council Dementia Research Development Fellowship (grant number 1100862) for this work. J.C.S is the recipient of an Australian National Health and Medical Research Investigator Grant (grant number 1173472), which supported this research. There were no other specific sources of funding for this work.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

References

  • 1. Glikmann‐Johnston Y, Carmichael AM, Mercieca EC, Stout JC. Real‐life' hippocampal‐dependent spatial memory impairments in Huntington's disease. Cortex 2019;119:46–60. [DOI] [PubMed] [Google Scholar]
  • 2. Ross CA, Reilmann R, Cardoso F, et al. Movement Disorder Society task force viewpoint: Huntington's disease diagnostic categories. Mov Disord Clin Pract 2019;6(7):541–546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Walker FO. Huntington's disease. Lancet 2007;369(9557):218–228. [DOI] [PubMed] [Google Scholar]
  • 4. Faria AV, Ratnanather JT, Tward DJ, Lee DS, van den Noort F, Wu D, et al. Linking white matter and deep gray matter alterations in premanifest Huntington disease. NeuroImage Clinical 2016;11:450–460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, et al. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Hum Brain Mapp 2014;35(3):792–809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. McColgan P, Seunarine KK, Razi A, et al. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease. Brain 2015;138(Pt 11):3327–3344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Chersi F, Burgess N. The cognitive architecture of spatial navigation: hippocampal and striatal contributions. Neuron 2015;88(1):64–77. [DOI] [PubMed] [Google Scholar]
  • 8. Hartley T, Lever C, Burgess N, O'Keefe J. Space in the brain: how the hippocampal formation supports spatial cognition. Philos Trans R Soc Lond Ser B Biol Sci 2014;369(1635):20120510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Goodroe SC, Starnes J, Brown TI. The complex nature of hippocampal‐striatal interactions in spatial navigation. Front Hum Neurosci 2018;12:250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Voermans NC, Petersson KM, Daudey L, Weber B, Van Spaendonck KP, Kremer HP, et al. Interaction between the human hippocampus and the caudate nucleus during route recognition. Neuron 2004;43(3):427–435. [DOI] [PubMed] [Google Scholar]
  • 11. Glikmann‐Johnston Y, Mercieca EC, Carmichael AM, Alexander B, Harding IH, Stout JC. Hippocampal and striatal volumes correlate with spatial memory impairment in Huntington's disease. J Neurosci Res 2021; 99(11): 2948–2963. [DOI] [PubMed] [Google Scholar]
  • 12. Friston KJ, Harrison L, Penny W. Dynamic causal modelling. NeuroImage 2003;19(4):1273–1302. [DOI] [PubMed] [Google Scholar]
  • 13. Friston KJ, Kahan J, Biswal B, Razi A. A DCM for resting state fMRI. NeuroImage 2014;94:396–407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Razi A, Kahan J, Rees G, Friston KJ. Construct validation of a DCM for resting state fMRI. NeuroImage 2015;106:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Razi A, Seghier ML, Zhou Y, McColgan P, Zeidman P, Park HJ, et al. Large‐scale DCMs for resting‐state fMRI. Netw Neurosci 2017;1(3):222–241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Scheller E, Abdulkadir A, Peter J, Tabrizi SJ, Frackowiak RSJ, Klöppel S. Interregional compensatory mechanisms of motor functioning in progressing preclinical neurodegeneration. NeuroImage 2013;75:146–154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Lahr J, Minkova L, Tabrizi SJ, Stout JC, Klöppel S, Scheller E. Working memory‐related effective connectivity in Huntington's disease patients. Front Neurol 2018;9:370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Huntington Study Group . Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 1996;11(2):136–142. [DOI] [PubMed] [Google Scholar]
  • 19. Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann Neurol 1997;41(5):689–692. [DOI] [PubMed] [Google Scholar]
  • 20. Nelson HE, Willison J, Owen AM. National adult reading test. Int J Geriatr Psychiatry 1992;7(2):533. [Google Scholar]
  • 21. Eaton WW, Muntaner C, Smith C, Tien A, Ybarra M. Center for epidemiologic studies depression scale: review and revision (CESD and CESD‐R). In: Maruish ME, ed. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. 3rd ed. Mahwah, NJ: Lawrence Erlbaum; 2004:363–377. [Google Scholar]
  • 22. Burgess N, O'Keefe J. Neural representations in human spatial memory. Trends Cogn Sci 2003;7(12):517–519. [DOI] [PubMed] [Google Scholar]
  • 23. Coppen EM, van der Grond J, Hafkemeijer A, Rombouts SARB, Roos RAC. Early grey matter changes in structural covariance networks in Huntington's disease. NeuroImage: Clinical 2016;12:806–814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Labuschagne I, Cassidy AM, Scahill RI, Johnson EB, Rees E, O'Regan A, et al. Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage Huntington's disease. J Int Neuropsychol Soc 2016;22(6):595–608. [DOI] [PubMed] [Google Scholar]
  • 25. Unschuld PG, Joel SE, Liu X, Shanahan M, Margolis RL, Biglan KM, et al. Impaired cortico‐striatal functional connectivity in prodromal Huntington's disease. Neurosci Lett 2012;514(2):204–209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas‐based interrogation of fMRI data sets. NeuroImage 2003;19(3):1233–1239. [DOI] [PubMed] [Google Scholar]
  • 27. Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User‐guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage 2006;31(3):1116–1128. [DOI] [PubMed] [Google Scholar]
  • 28. Duvernoy HM, Vannson JL, Bourgouin P, Cabanis EA, Cattin F, Guyot J, et al. The Human Brain: Surface, Three‐Dimensional Sectional Anatomy with MRI, and Blood Supply. Vienna, Austria: Springer; 2012. [Google Scholar]
  • 29. Looi JCL, Lindberg O, Liberg B, Tatham V, Kumar R, Maller J, et al. Volumetrics of the caudate nucleus: reliability and validity of a new manual tracing protocol. Psychiatry Res Neuroimaging 2008;163(3):279–288. [DOI] [PubMed] [Google Scholar]
  • 30. Looi J, Svensson L, Lindberg O, et al. Putaminal volume in frontotemporal lobar degeneration and Alzheimer disease: differential volumes in dementia subtypes and controls. Am J Neuroradiol 2009;30(8):1552–1560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42(9):1743. [DOI] [PubMed] [Google Scholar]
  • 32. Free S, Bergin P, Fish D, Cook M, Shorvon S, Stevens J. Methods for normalization of hippocampal volumes measured with MR. Am J Neuroradiol 1995;16(4):637–643. [PMC free article] [PubMed] [Google Scholar]
  • 33. Friston KJ, Litvak V, Oswal A, et al. Bayesian model reduction and empirical Bayes for group (DCM) studies. NeuroImage 2016;128:413–431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Zeidman P, Jafarian A, Seghier ML, Litvak V, Cagnan H, Price CJ, et al. A guide to group effective connectivity analysis, part 2: second level analysis with PEB. NeuroImage 2019;200:12–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Papoutsi M, Labuschagne I, Tabrizi SJ, Stout JC. The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation. Mov Disord 2014;29(5):673–683. [DOI] [PubMed] [Google Scholar]
  • 36. Andrews SC, Domínguez JF, Mercieca EC, Georgiou‐Karistianis N, Stout JC. Cognitive interventions to enhance neural compensation in Huntington's disease. Neurodegener Dis Manag 2015;5(2):155–164. [DOI] [PubMed] [Google Scholar]
  • 37. Dominguez DJ, Egan GF, Gray MA, Poudel GR, Churchyard A, Chua P, et al. Multi‐modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE‐HD study. PLoS One 2013;8(9):e74131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK‐HD study: cross‐sectional analysis of baseline data. Lancet Neurology 2009;8(9):791–801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK‐HD study: analysis of 24 month observational data. Lancet Neurology 2012;11(1):42–53. [DOI] [PubMed] [Google Scholar]
  • 40. Tabrizi SJ, Scahill RI, Durr A, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK‐HD study: the 12‐month longitudinal analysis. Lancet Neurol 2011;10(1):31–42. [DOI] [PubMed] [Google Scholar]
  • 41. Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, et al. Predictors of phenotypic progression and disease onset in premanifest and early‐stage Huntington's disease in the TRACK‐HD study: analysis of 36‐month observational data. Lancet Neurology 2013;12(7):637–649. [DOI] [PubMed] [Google Scholar]
  • 42. Feigin A, Ghilardi MF, Huang C, Ma Y, Carbon M, Guttman M, et al. Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol 2006;59(1):53–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Georgiou‐Karistianis N, Poudel GR, Dominguez DJ, Langmaid R, Gray MA, Churchyard A, et al. Functional and connectivity changes during working memory in Huntington's disease: 18 month longitudinal data from the IMAGE‐HD study. Brain Cogn 2013;83(1):80–91. [DOI] [PubMed] [Google Scholar]
  • 44. Gray MA, Egan GF, Ando A, Churchyard A, Chua P, Stout JC, et al. Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE‐HD study. Exp Neurol 2013;239:218–228. [DOI] [PubMed] [Google Scholar]
  • 45. Paulsen JS, Zimbelman JL, Hinton SC, Langbehn DR, Leveroni CL, Benjamin ML, et al. fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. AJNR Am J Neuroradiol 2004;25(10):1715–1721. [PMC free article] [PubMed] [Google Scholar]
  • 46. Poudel GR, Stout JC, Dominguez DJ, et al. Functional changes during working memory in Huntington's disease: 30‐month longitudinal data from the IMAGE‐HD study. Brain Struct Funct 2015;220(1):501–512. [DOI] [PubMed] [Google Scholar]
  • 47. Klöppel S, Gregory S, Scheller E, Minkova L, Razi A, Durr A, et al. Compensation in preclinical Huntington's disease: evidence from the track‐on HD study. EBioMedicine 2015;2(10):1420–1429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou‐Karistianis N. Brain compensation during visuospatial working memory in premanifest Huntington's disease. Neuropsychologia 2020;136:107262. [DOI] [PubMed] [Google Scholar]
  • 49. McColgan P, Gregory S, Zeun P, Zarkali A, Johnson EB, Parker C, et al. Neurofilament light‐associated connectivity in young‐adult Huntington's disease is related to neuronal genes. Brain 2022;145(11):3953–3967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Byrne LM, Rodrigues FB, Johnson EB, Wijeratne PA, De Vita E, Alexander DC, et al. Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease. Sci Transl Med 2018;10(458): eaat7108. [DOI] [PubMed] [Google Scholar]
  • 51. Callahan JW, Abercrombie ED. Age‐dependent alterations in the cortical entrainment of subthalamic nucleus neurons in the YAC128 mouse model of Huntington's disease. Neurobiol Dis 2015;78:88–99. [DOI] [PubMed] [Google Scholar]
  • 52. Ravalia AS, Lau J, Barron JC, Purchase SLM, Southwell AL, Hayden MR, et al. Super‐resolution imaging reveals extrastriatal synaptic dysfunction in presymptomatic Huntington disease mice. Neurobiol Dis 2021;152:105293. [DOI] [PubMed] [Google Scholar]
  • 53. Paulsen JS. Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep 2011;11(5):474–483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Stout JC, Jones R, Labuschagne I, O'Regan AM, Say MJ, Dumas EM, et al. Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease. J Neurol Neurosurg Psychiatry 2012;83(7):687–694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 2011;25(1):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Begeti F, Schwab LC, Mason SL, Barker RA. Hippocampal dysfunction defines disease onset in Huntington's disease. J Neurol Neurosurg Psychiatry 2016;87(9):975–981. [DOI] [PubMed] [Google Scholar]
  • 57. Pirogovsky E, Nicoll DR, Challener DM, Breen E, Gluhm S, Corey‐Bloom J, et al. The visual spatial learning test: differential impairment during the premanifest and manifest stages of Huntington's disease. J Neuropsychol 2015;9(1):77–86. [DOI] [PubMed] [Google Scholar]
  • 58. Lynch K. The Image of the City. Cambridge MA: MIT Press; 1960. [Google Scholar]
  • 59. Siegel AW, White SH. The development of spatial representations of large‐scale environments. In: Reese HW, ed. Advances in Child Behaviour and Development. New York: Academic Press; 1975:9–55. [DOI] [PubMed] [Google Scholar]
  • 60. Postma A, Kessels RPC, Van Asselen M. How the brain remembers and forgets where things are: the neurocognition of object‐location memory. Neurosci Biobehav Rev 2008;32(8):1339–1345. [DOI] [PubMed] [Google Scholar]
  • 61. Schmidt ME, Buren C, Mackay JP, Cheung D, Dal Cengio L, Raymond LA, et al. Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico‐striatal co‐culture model of Huntington disease. BMC Biol 2018;16(1):58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Hannan AJ. Synaptopathy, circuitopathy and the computational biology of Huntington's disease. BMC Biol 2018;16(1):71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Bates GP, Dorsey R, Gusella JF, et al. Huntington disease. Nat Rev Dis Primers 2015;1:15005. [DOI] [PubMed] [Google Scholar]
  • 64. Marinina KS, Bezprozvanny IB, Egorova PA. Anxiety, memory, and social impairments in the YAC128 mouse model of Huntington's disease. J Huntington's Dis 2024;13(4):431–448. [DOI] [PubMed] [Google Scholar]
  • 65. Southwell AL, Kordasiewicz HB, Langbehn D, Skotte NH, Parsons MP, Villanueva EB, et al. Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease. Sci Transl Med 2018;10(461): eaar3959. [DOI] [PubMed] [Google Scholar]
  • 66. Miguez A, Garcia‐Diaz Barriga G, Brito V, Straccia M, Giralt A, Gines S, et al. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up‐regulation and astrocyte‐mediated inflammation. Hum Mol Genet 2015;24(17):4958–4970. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data S1. Supporting Information.

MDS-40-1692-s001.docx (15.2KB, docx)

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.


Articles from Movement Disorders are provided here courtesy of Wiley

RESOURCES